Organovo Signs Worldwide Licensing Agreement with UniQuest

Organovo (NYSEMKT:ONVO) and the University of Queensland’s technology transfer and commercialization company have partnered under a worldwide licensing agreement to patent applications related to kidney cells developed from induced pluripotent stem cells. Previously this year, Organovo produced 3D printed kidney cells and Professor Melissa Little, of the University of Queensland’s Institute for Molecular Bioscience, illustrated the ability to create a miniature kidney.
According to 3D Printing Industry:

Building off of previous work to grow a “mini-kidney” containing two types of kidney cells, Prof. Little’s team published research outlining their groundbreaking ability to, relying on iPSCs, grow a mini-kidney made up of all of the cell types normally present in a human kidney, with the necessary vascularization, as well.  Prof. Little says of the research, published last week in Nature, “The mini-kidney we have been able to grow is very complex and more like the real organ. This is important for drug testing as we hope these mini-kidneys will respond to the drugs as a normal organ might.”

Click here to read the full article on 3D Printing Industry.